Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Biotechnological applications of bacteriophages: State of the art

Texto completo
Autor(es):
Harada, Liliam K. [1] ; Silva, Erica C. [1] ; Campos, Welida F. [1] ; Del Fiol, Fernando S. [1] ; Vila, Marta [1] ; Dabrowska, Krystyna [2] ; Krylov, Victor N. [3] ; Balcao, Victor M. [4, 1]
Número total de Autores: 8
Afiliação do(s) autor(es):
[1] Univ Sorocaba, Ibs 2 Intelligent Biosensing & Biomol Stabilizat, PhageLab Lab Biofilms & Bacteriophages, Sorocaba, SP - Brazil
[2] Polish Acad Sci, Inst Immunol & Expt Therapy, Bacteriophage Lab, Wroclaw - Poland
[3] Russian Acad Med Sci, Mechnikov Res Inst Vaccines & Sera, Lab Genet Bacteriophages, State Inst Genet & Select Ind Microorganisms, 1st Dorozhnii Proezd 1, Moscow 113545 - Russia
[4] Univ Minho, CEB Ctr Biol Engn, Braga - Portugal
Número total de Afiliações: 4
Tipo de documento: Artigo Científico
Fonte: MICROBIOLOGICAL RESEARCH; v. 212, p. 38-58, 2018.
Citações Web of Science: 14
Resumo

Bacteriophage particles are the most abundant biological entities on our planet, infecting specific bacterial hosts in every known environment and being major drivers of bacterial adaptive evolution. The study of bacteriophage particles potentially sheds light on the development of new biotechnology products. Bacteriophage therapy, although not new, makes use of strictly lytic phage particles as an alternative in the antimicrobial treatment of resistant bacterial infections and is being rediscovered as a safe method due to the fact that these biological entities devoid of any metabolic machinery do not have affinity to eukaryotic cells. Furthermore, bacteriophage-based vaccination is emerging as one of the most promising preventive strategies. This review paper discusses the biological nature of bacteriophage particles, their mode(s) of action and potential exploitation in modern biotechnology. Topics covered in detail include the potential of bacteriophage particles in human infections (bacteriophage therapy), nanocages for gene delivery, food biopreservation and safety, biocontrol of plant pathogens, phage display, bacterial biosensing devices, vaccines and vaccine carriers, biofilm and bacterial growth control, surface disinfection, corrosion control, together with structural and functional stabilization issues. (AU)

Processo FAPESP: 16/08884-3 - PneumoPhageColor - desenvolvimento de um kit de biodetecção colorimétrica de Pseudomonas aeruginosa com base em partículas fágicas
Beneficiário:Vitor Manuel Cardoso Figueiredo Balcão
Linha de fomento: Auxílio à Pesquisa - Regular
Processo FAPESP: 16/12234-4 - TransAppIL - permeação cutânea de entidades proteicas estabilizadas estruturalmente e funcionalmente, carreadas por líquidos iônicos
Beneficiário:Marta Maria Duarte Carvalho Vila
Linha de fomento: Auxílio à Pesquisa - Regular
Processo FAPESP: 16/16641-3 - Estabilização estrutural e funcional de sericina em hidrogel biopolissacarídico: bio-origami para a regeneração de pele
Beneficiário:Liliam Katsue Harada Rocha
Linha de fomento: Bolsas no Brasil - Mestrado